Enzo Biochem (ENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 07-2023 | 07-2022 | 07-2021 | 07-2020 | 07-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 82,373 | 21,603 | 13,524 | 47,865 | 60,146 |
| Marketable Securities | N/A | N/A | 29,978 | 0 | N/A |
| Receivables | 4,808 | 4,762 | 10,198 | 9,141 | 10,738 |
| Inventories | 7,939 | 9,516 | 12,652 | 7,784 | 7,842 |
| Other current assets | 0 | 4,126 | 0 | 0 | 0 |
| TOTAL | $98,456 | $42,823 | $70,582 | $68,765 | $81,453 |
| Non-Current Assets | |||||
| PPE Net | 13,086 | 11,636 | 16,585 | 14,482 | 14,254 |
| Intangibles | 0 | 0 | 7,696 | 7,990 | 8,484 |
| Other Non-Current Assets | 10,338 | 21,152 | 18,828 | 21,301 | 2,449 |
| TOTAL | $23,424 | $32,788 | $43,109 | $43,773 | $25,187 |
| Total Assets | $121,880 | $75,611 | $113,691 | $112,538 | $106,640 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 7,000 | N/A |
| Accounts payable and accrued liabilities | 3,575 | 3,715 | 8,123 | 8,503 | 7,256 |
| Accrued Expenses | 11,743 | 8,179 | 14,301 | 12,833 | 8,362 |
| Other current liabilities | 75 | 229 | 233 | 344 | 391 |
| TOTAL | $39,989 | $13,019 | $26,076 | $32,801 | $16,009 |
| Non-Current Liabilities | |||||
| Long Term Debt | 269 | 4,077 | 4,356 | 4,485 | 4,179 |
| Other Non-Current Liabilities | 3,160 | 4,053 | 14,673 | 16,871 | 424 |
| TOTAL | $3,429 | $8,130 | $19,029 | $21,356 | $4,603 |
| Total Liabilities | $43,418 | $21,149 | $45,105 | $54,157 | $20,612 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,490 | 48,720 | 48,472 | 47,895 | 47,557 |
| Common Shares | 499 | 487 | 485 | 479 | 476 |
| Retained earnings | -268,350 | -288,638 | -270,377 | -278,252 | -249,732 |
| Other shareholders' equity | 1,878 | 3,151 | 1,352 | 1,681 | 2,580 |
| TOTAL | $78,462 | $54,462 | $68,586 | $58,381 | $86,028 |
| Total Liabilities And Equity | $121,880 | $75,611 | $113,691 | $112,538 | $106,640 |